T2347
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T2347, covering 2017-01-23 to 2017-01-23. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Assessment of T2347 Versus Xalacom® in Ocular Hypertensive or Glaucomatous Patients [Phase 3]